KCM
NUVB icon

Knoll Capital Management’s Nuvation Bio NUVB Stock Holding History

Knoll Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.08M Buy
1,598,591
+100,000
+7% +$489K 5.06% 7
2026
Q1 		$6.43M Hold
1,498,591
– – 3.57% 13
2025
Q4 		$13.4M Buy
1,498,591
+473,591
+46% +$2.93M 6.16% 3
2025
Q3 		$5.54M Hold
1,025,000
– – 2.97% 14
2025
Q2 		$2.92M Hold
1,025,000
– – 2.08% 16
2025
Q1 		$1.8M Buy
+1,025,000
New +$2.33M 1.17% 20

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Knoll Capital Management's NUVB Position: Q2 2026 in Review

Knoll Capital Management increased its Nuvation Bio (NUVB) stake by 6.7% in Q2 2026, buying an estimated $489K and bringing the position to 1,598,591 shares worth $9.08M. The position accounts for 5.06% of the portfolio, ranked #7.

Knoll Capital Management first reported a position in NUVB in Q1 2025 and has held it in 6 quarters since. The position peaked at $13.4M in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Knoll Capital Management held 1,598,591 shares of Nuvation Bio worth $9.08M as of Q2 2026.
  • Knoll Capital Management bought 100,000 Nuvation Bio shares in Q2 2026, an estimated $489K.
  • Nuvation Bio made up 5.06% of Knoll Capital Management's portfolio in Q2 2026, its #7 holding.
  • Knoll Capital Management first reported a position in Nuvation Bio in Q1 2025 and has held it in 6 quarters since.
  • Knoll Capital Management's Nuvation Bio position peaked at $13.4M in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Knoll Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.